Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Anticipated CAGR of the Viral Diagnostic Test Kits Market, and What Factors Will Drive It?
There has been a substantial expansion in the market size for viral diagnostic test kits in the past few years. The market is projected to escalate from $16.26 billion in 2024 to $17.62 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. Factors such as heightened healthcare spending, enhanced global travel, an upsurge in chronic viral infections, increased demand for home testing kits, and the evolution of personalized medicine, have contributed to the growth in the historical period.
It’s predicted that there will be a significant increase in the viral diagnostic test kits market size in the forthcoming years, escalating to a value of $23.99 billion in 2029 with a compound annual growth rate (CAGR) of 8.0%. Factors that will contribute to this surge during the anticipated period include the rise in Ebola virus occurrences, climbing hemorrhagic fever cases, escalating viral infection rates, a growing number of respiratory syncytial virus cases, and an increase in hepatitis prevalence. Key trends anticipated in the forecast period comprise of advancements in technology, point-of-care testing, the application of AI and data analytics, incorporation with digital health records, and the introduction of next-generation sequencing.
Which Major Market Drivers Are Expected to Boost the Viral Diagnostic Test Kits Market’s Growth Potential?
An increase in viral infection occurrences is likely to bolster the expansion of the viral diagnostic test kits market. These viral infections originate from tiny viruses that penetrate host cells, reproduce internally and can trigger a wide array of symptoms of varying severity in numerous body parts. Factors contributing to the rise in viral infections include global travel, urbanization, climate change-related impacts on vector-borne diseases and the evolution of viral strains which can instigate new outbreaks or spread to new geographical areas. Viral diagnostic test kits play a crucial role in determining and verifying the existence of specific viral infections in patients by disclosing viral nucleic acids (RNA or DNA), antigens or antibodies in biological samples like blood, saliva or nasal swabs. For example, according to the US-based national public health authority, the Centers for Disease Control and Prevention (CDC), there were 2,126 new acute hepatitis B cases along with 16,729 new chronic hepatitis B cases reported in 2022. Furthermore, the rates of acute hepatitis B reported in 14 jurisdictions in the US during this period exceeded the national average. Consequently, the growing prevalence of viral infections is pushing the growth of the viral diagnostic test kits market.
Explore Comprehensive Insights Into The Global Viral Diagnostic Test Kits Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp
Who Are the Top Companies Contributing to the Growth of the Viral Diagnostic Test Kits Market?
Major companies operating in the viral diagnostic test kits market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
How Are Technological Trends Affecting the Growth and Development of the Viral Diagnostic Test Kits Market?
Leading firms in the viral diagnostic test kit industry are pioneering new products like virus detection kits as part of their strategy to maintain market dominance. A virus detection kit serves as a diagnostic aid that can spot the presence of specific viruses in biological materials, delivering prompt and precise outcomes for effective disease surveillance and control. For example, BlueStain Global Ltd, a UK-based company unveiled its MPox virus detection kit in August 2024. This rapid diagnostic test is specifically made to identify the mpox virus swiftly and accurately, yielding results within 15 to 30 minutes. The development of this innovative kit is aimed at improving public health action by enabling early detection and management of mpox outbreaks, primarily in places with limited resources.
Secure Your Global Viral Diagnostic Test Kits Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report
Which Industry Segments Are Leading the Development and Expansion of the Viral Diagnostic Test Kits Market?
The viral diagnostic test kits market covered in this report is segmented –
1) By Test: Traditional Tests, Rapid Test
2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types
3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users
Subsegments:
1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing
2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests
What Are the Key Regions Powering Growth in the Viral Diagnostic Test Kits Market?
North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Viral Diagnostic Test Kits Market Defined Across Different Regions?
Viral diagnostic test kits are medical devices or tools used to detect the presence of viral infections in clinical samples taken from patients. These kits typically contain reagents, antibodies, or other substances interacting with specific viral antigens or genetic material to produce a measurable signal. The tests can identify the presence of viral particles, antigens, or genetic material (like RNA or DNA) in samples such as blood, saliva, nasal swabs, or other bodily fluids.
Browse Through More Similar Reports By The Business Research Company:
COVID-19 Detection Test Kits and Consumables Global Market Report 2024
Anesthesia And Respiratory Devices Market Opportunities And Strategies Forecast To 2030
https://www.thebusinessresearchcompany.com/report/anesthesia-and-respiratory-devices-market
COVID-19 Rapid Test Kits Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
